Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/145259
Full metadata record
DC FieldValueLanguage
dc.creatorMello, RA
dc.creatorZhu, JH
dc.creatorIavelberg, J
dc.creatorPotim, AH
dc.creatorSimonetti, D
dc.creatorJúnior, JAS
dc.creatorCastelo-Branco, P
dc.creatorPozza, DH
dc.creatorTajima, CC
dc.creatorTolia, M
dc.creatorAntoniou, G
dc.date.accessioned2022-11-17T11:33:03Z-
dc.date.available2022-11-17T11:33:03Z-
dc.date.issued2020
dc.identifier.issn2218-6751
dc.identifier.urihttps://hdl.handle.net/10216/145259-
dc.description.sponsorshipWe would like to acknowledge CNPQ research grant 402621/2016-6.
dc.language.isoeng
dc.publisherAME
dc.relation.ispartofTranslational Lung Cancer Research, vol.9(6), p. 2311-2314
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleCurrent and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: Is there a role in clinical practice?
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.21037/tlcr-20-625
dc.relation.publisherversionhttps://tlcr.amegroups.com/article/view/41772/html
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.21037-tlcr-20-625.pdf162.86 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons